Companies: 10,795·Total market cap: $144.5T
RxSight, Inc.

RxSight, Inc.

RXSTNASDAQHealthcare● Active
$4.95
$-0.05(-1.00%)
Market Cap$204913210
P/E Ratio
52W High$16
52W Low$4.7

RxSight, Inc. (RXST) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

rxst · stock forecast · 12 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 12 Wall Street analysts in the past 3 months

SellBuy

Hold

12 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
3
Hold
7
Sell
2
Strong Sell
0
Total: 12 · Buy rate: 25.0%

12-Month Price Target

High

$11.00

Consensus

$10.33

+108.7% upside

Low

$9.00

Median: $11 · Last Close: $4.95

The RxSight, Inc. (RXST) analyst consensus is Hold, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month RXST price target is $10.33, representing +108.7% upside from the current price of $4.95.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $10 (108.7%)

Consensus Target

$10.33

108.7% upside

High Target

$11

122.2%

Low Target

$9

81.8%

Current Price

$4.95

as of today

Based on analyst price targets, the RXST stock price prediction for the next 12 months ranges from $9 to $11. The consensus RXST price forecast of $10.33 implies 108.7% upside from the current price of $4.95.

Short-Term Price Prediction

Low Activity

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$4.705.00%

1-day model range: $4.61–$4.8. Peak: $4.8 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027-44.2%
2028-56.5%
2029-61.3%
2030-63.5%
2031-64.5%
Confidence:Very Low
⚠️ 2027 projections carry Very Low confidence. Treat as directional guidance only.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

🚫

Insufficient Trading Activity — Sentiment Signals Disabled

This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.

RSI (14)28.7
MACDBEARISH

Moving Averages · RXST · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$4.96SELL
MA 10$5.26SELL
MA 20$5.56SELL
MA 50$6.38SELL
MA 100$7.28SELL
MA 200$8.52SELL
Current $RXST · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$5.04SELL
EMA 10$5.24SELL
EMA 20$5.58SELL
EMA 50$6.30SELL
EMA 100$7.22SELL
EMA 200$9.69SELL
Current $RXST · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Needham2026-05-07
Maintains
BuyBuy
Wells Fargo2026-05-07
Maintains
Equal WeightEqual Weight
Stifel2026-03-09
Maintains
HoldHold
Needham2026-02-26
Maintains
BuyBuy
Piper Sandler2026-02-26
Maintains
NeutralNeutral
UBS2026-02-26
Maintains
NeutralNeutral
Piper Sandler2026-01-20
Maintains
NeutralNeutral
Morgan Stanley2025-12-02
Maintains
Equal WeightEqual Weight
Wells Fargo2025-11-06
Maintains
Equal WeightEqual Weight
JP Morgan2025-11-06
Maintains
UnderweightUnderweight

Wall Street analysts have recently issued updated ratings on RxSight, Inc. (RXST) stock. Of the recent 89 rating actions, 2 were upgrades and 9 were downgrades. 12 analysts currently cover RXST.

Analyst Recommendation Trends

Buy ratings11
Hold ratings11
Sell ratings101

RXST analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$140M

↑ 8.3% YoY

Revenue Next Year

$132M

↓ 6.0% YoY

EPS This Year

$-0.72

EPS Next Year

$-1.05

↑ 45.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast RXST EPS of $-0.72 for the current fiscal year, based on estimates from 4 analysts. The RXST revenue forecast is $140M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The RXST stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus RXST price target is $10.33 (+108.7% upside), with an analyst consensus of Hold.

The RXST short-term stock prediction for tomorrow is $4.70 (-5.00%). The RXST stock prediction for 2030 projects a range of $2–$2.

RxSight, Inc. trades on NASDAQ under the ticker RXST. The RXST stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 25% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

RXST forecast · 8 questions

According to 12 Wall Street analysts, the average 12-month RXST price target is $10.33, with a high forecast of $11.00 and a low of $9.00. The median price target is shown in the chart above when available. This implies +108.7% potential upside from the current price of $4.95.

RXST price targetWhat is RXST price targetRXST analyst price targetRXST 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.